- Report
- May 2025
- 171 Pages
Global
From €5358EUR$5,850USD£4,561GBP
- Report
- May 2025
- 194 Pages
Global
From €5358EUR$5,850USD£4,561GBP
- Report
- May 2025
- 89 Pages
Global
From €5358EUR$5,850USD£4,561GBP
- Report
- May 2025
- 93 Pages
Global
From €5358EUR$5,850USD£4,561GBP
- Report
- May 2025
- 93 Pages
Global
From €5358EUR$5,850USD£4,561GBP
- Report
- May 2025
- 78 Pages
Global
From €5358EUR$5,850USD£4,561GBP
- Report
- May 2025
- 193 Pages
Global
From €5358EUR$5,850USD£4,561GBP
- Report
- May 2025
- 590 Pages
Global
From €5358EUR$5,850USD£4,561GBP
- Report
- March 2025
- 200 Pages
Global
From €4112EUR$4,490USD£3,501GBP
- Report
- February 2025
- 200 Pages
Global
From €4112EUR$4,490USD£3,501GBP
- Report
- March 2025
- 150 Pages
Global
From €4442EUR$4,850USD£3,782GBP
- Report
- March 2025
- 150 Pages
Global
From €4442EUR$4,850USD£3,782GBP
- Report
- March 2025
- 149 Pages
Global
From €2747EUR$2,999USD£2,338GBP
- Report
- August 2024
- 140 Pages
Global
From €2747EUR$2,999USD£2,338GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1832EUR$2,000USD£1,559GBP
- Clinical Trials
- April 2025
- 120 Pages
Global
From €2747EUR$3,000USD£2,339GBP
- Clinical Trials
- April 2025
- 280 Pages
Global
From €4579EUR$5,000USD£3,899GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1374EUR$1,500USD£1,170GBP
- Clinical Trials
- April 2025
- 550 Pages
Global
From €4579EUR$5,000USD£3,899GBP
- Clinical Trials
- April 2025
- 115 Pages
Global
From €1832EUR$2,000USD£1,559GBP

Cancer Immunotherapy is a type of Immune Disorders Drugs that uses the body's own immune system to fight cancer. It works by stimulating the body's natural defense system to recognize and attack cancer cells. This type of therapy is used to treat a variety of cancers, including melanoma, lymphoma, and leukemia. It can also be used to treat other types of cancer, such as breast, lung, and colorectal cancer.
Cancer Immunotherapy is a rapidly growing field, with many new treatments being developed. It is an important part of the overall cancer treatment landscape, as it can provide a more targeted approach to treating cancer. It can also be used in combination with other treatments, such as chemotherapy and radiation therapy, to improve outcomes.
Some of the companies in the Cancer Immunotherapy market include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Roche. These companies are developing a range of treatments, including monoclonal antibodies, vaccines, and cell-based therapies. Show Less Read more